CMTA
Clementia Pharmaceuticals Inc.
CMTA
CMTA
Delisted
CMTA was delisted on the 17th of April, 2019.
27 hedge funds and large institutions have $263M invested in Clementia Pharmaceuticals Inc. in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 5 closing their positions.
Holders
27
Holders Change
-2
Holders Change %
-6.9%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
8
Reduced
8
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BBA
1
Baker Bros. Advisors
New York
|
$21.6M |
| 2 |
AG
2
Artal Group
Luxembourg
|
$7.72M |
| 3 |
3
JPMorgan Chase & Co
New York
|
$11.6M |
| 4 |
OM
4
Opaleye Management
Boston,
Massachusetts
|
$1.66M |
| 5 |
BC
5
Birchview Capital
Burlington,
Vermont
|
$1.36M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $5K | -$14.7K | -1,357 | -75% |
|
27
Fidelity Investments
Boston,
Massachusetts
| – | -$6.58M | -500,000 | Closed |
|
28
Alyeska Investment Group
Chicago,
Illinois
| – | -$2.97M | -225,862 | Closed |
|
29
D.E. Shaw & Co
New York
| – | -$211K | -16,026 | Closed |
|
|
WJA
30
Williams Jones & Associates
New York
| – | -$133K | -10,100 | Closed |
|
|
AAMU
31
Amundi Asset Management US
Boston,
Massachusetts
| – | -$61K | -4,600 | Closed |
|